- Home
- LNTH vs FN Comparison
LNTH vs FN Comparison
Compare LNTH & FN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- FN
- Stock Information
- Founded
- LNTH 1956
- FN 1999
- Country
- LNTH United States
- FN Cayman Islands
- Employees
- LNTH N/A
- FN N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- FN Telecommunications Equipment
- Sector
- LNTH Health Care
- FN Utilities
- Exchange
- LNTH Nasdaq
- FN Nasdaq
- Market Cap
- LNTH 7.5B
- FN 8.2B
- IPO Year
- LNTH 2015
- FN 2010
- Fundamental
- Price
- LNTH $75.56
- FN $232.65
- Analyst Decision
- LNTH Strong Buy
- FN Buy
- Analyst Count
- LNTH 5
- FN 7
- Target Price
- LNTH $133.80
- FN $240.71
- AVG Volume (30 Days)
- LNTH 1.5M
- FN 718.0K
- Earning Date
- LNTH 05-07-2025
- FN 05-05-2025
- Dividend Yield
- LNTH N/A
- FN N/A
- EPS Growth
- LNTH N/A
- FN 18.98
- EPS
- LNTH 3.53
- FN 8.97
- Revenue
- LNTH $1,536,699,000.00
- FN $3,262,896,000.00
- Revenue This Year
- LNTH $4.63
- FN $21.16
- Revenue Next Year
- LNTH $9.35
- FN $12.34
- P/E Ratio
- LNTH $21.40
- FN $25.96
- Revenue Growth
- LNTH 12.53
- FN 17.14
- 52 Week Low
- LNTH $73.11
- FN $148.55
- 52 Week High
- LNTH $126.89
- FN $281.79
- Technical
- Relative Strength Index (RSI)
- LNTH 32.65
- FN 61.22
- Support Level
- LNTH $73.75
- FN $222.67
- Resistance Level
- LNTH $76.34
- FN $241.00
- Average True Range (ATR)
- LNTH 2.50
- FN 7.86
- MACD
- LNTH -0.09
- FN 0.42
- Stochastic Oscillator
- LNTH 23.36
- FN 70.83
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About FN Fabrinet
Fabrinet provides advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advanced packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.